Skip to main content

Table 1 Baseline characteristics of included surgeries

From: Compliance to perioperative anticoagulation protocols in elderly patients undergoing elective orthopedic procedures: a retrospective observational cohort study on 548 patients

 

VKA users

n = 319

DOAC users

n = 229

P-value

Sex, (%)

0.7

 Male

46

48

 

 Female

54

52

 

Mean age (SD)

78,2

(5,2)

77,5

(4,9)

0.2

VKA users (%)

 Acenocoumarol

53

  

 Phenprocoumon

47

  

DOAC users (%)

 Dabigatran

 

33

 

 Rivaroxaban

 

31

 

 Apixaban

 

28

 

 Edoxaban

 

8

 

TAI users (%)

1

1

0.7

Administrating tranexamic acid (%)

30

39

0.02

Comorbidities (%)

 Coronary heart disease

19

23

0.3

 CVA/TIA

20

19

0.7

 Decompensatio cordis

20

14

0.1

 Diabetes mellitus

3

6

0.7

 Valvular heart disease

23

10

 < 0.001

 Hypertension

67

63

0.4

 Peripheral arterial disease

4

8

0.1

 Heart rhythm disorder

84

91

0.02

 Thrombosis

17

12

0.1

 Clotting disorder

1

0

0.1

Renal impairment (%)

13

9

0.2

 eGFR 30—50

11

8

 

 eGFR < 30

2

1

 

Surgical bleeding risk (%)

  

0.3

 Low

0

0

 

 Intermediate

17

14

 

 High

83

86

 

ASA score (%)

  

0.3

 II

50

50

 

 III

48

49

 

 IV

2

1

 

Tourniquet use (%)

22

26

0.3

Bellovac drain (%)

15

13

0.4

  1. DOAC Direct oral anticoagulants, eGFR estimated glomerular filtration rate in ml/min, TAI thrombocyte aggregation inhibitors, VKA Vitamin K antagonist